Saratov JOURNAL of Medical and Scientific Research

Modern approach to therapy of allergic conjunctivitis

Year: 2018, volume 14 Issue: №4 Pages: 938-941
Heading: Ophtalmology Article type: Review
Authors: Narzikulova K.l., Mirrakhimova S.Sh., Safarov J.O., Ibragimova N.N.
Organization: Buhara state medical institute, Tashkent Medical Academy
Summary:

Today allergic eye diseases are the one of most important problems for modern medicine. Despite that many literature sources characterize eye disorders in allergy, finding an effective therapy for these conditions is still a serious issue for ophthalmologists. Effective treatment of allergic conjunctivitis requires clear understanding of pathogenesis of this disease. According to this conception physician can build the plan of therapy for individual patient with the choice of proper drug. This article is a systemic review of latest data from literature that is devoted to pathogenetic therapy of allergic conjunctivitis. Analysis of many scientific works shows that olopatadine and cromoglicic acid are the most useful drugs among modern medications.

Bibliography:
1 Ilyina NM. Allergic rhinitis. Allergy, asthma and clinical immunology 2007; 4 (20): 20-4
2 Maychuk UF. Modern aspects of eye allergy farmacotherapy. Journal of Ophthalmology 2000; (5): 10-4
3 Maychuk YF. Allergic diseases eye. M.: Medicine, 2012; 224 p.
4 Maychuk YF. Season pollinose conjunctivitis is the most spread form of eye allergy. Russian Journal of Ophthalmology 2010; (1): 37-41
5 Maychuk YuF, Haitova KN, Grishakova MB. Levokobastine eye drops in therapy of allergic conjunctivitises. In: V Rus nat Congress "Human and medicine" 2008; 127-8
6 Allergy and immunology: National guideline. M.: GEOTAR-Media, 2009
7 Baranov АА ed. Allergology and immunology. 2011
8 Bogacka F. Epidemiology of allergic eye disease. Pol Merkuriuzs Lek 2003; (84): 714-5
9 Remhard T, Larkin F. Cornea and external eye disease. Springer 2006; 229 p.
10 World Health Organization: Prevention of allergic asthma. WHO Geneva WHO/NMH/MNC/CRA/ 03.02.2003
11 Ono SL, Abelson MB. Allergic conjunctivitis update on pathophysiology and prospects for future treatment. J Allergy Chn Immunol 2005; (115): 118-22.12 Palmares J, Larkin F. Ocular Allergy. Medisa, 2007; 94 p.
13 Berdy GJ, Abelson MB, George MA, et al. Allergic conjunctivitis: a survey of new antihistamines. J Ocular Pharmacol 2010; (7): 313-4
14 Frostad AB, Olsen AK. A comparison of topical levocabastine and sodium cromoglycate eyedrops in the treatment of pollen-provoked allergic conjunctivitis. Clin Exp Allergy 2013; 23 (40): 6-9
15 Laner R, Finegold I, D'Arienzo P. Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the cohjunctival allergen challenge model. Curr Med Res Opin 2004; (20): 2644-51
16 Moller C, BJ4rksten B, Nillson G, et al. The precision of the conjunctival provocation test with allergen. Allergy 2014; (39): 37-41
17 Johansson SG, Bieber N, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the nomenclature reviewcommitteeoftheWorldAllergy Organisation, October 2003 Journal of Allergy and Clinical Immunology 2004; (113): 832-6
18 Bonini St, Pierdomenico R, Bonini S. Levocabastine eye drops in vernal keratoconjunctivitis. Allergy 2013; 48: 36-41.
19 Abelson MB, Weintraub D. Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis. Eur J Ophthalmol 2014; 4 (2): 91-101
20 Azevedo M, Castel-Branco MG, Ferraz Oliveira J, et al. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis. Clin Exp Allergy 2011; 21 (6): 89-94
21 Davies BH, Mulhns J. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis. Allergy 2013; 48 (51): 9-24
22 Bende M, Pipkorn U. Topical levocabastine, a selective H1-antagonist in seasonal allergic conjunctivitis. Allergy 2007; 42 (51): 2-5
23 Weston JH, Udell IJ, Abelson MB. H1-receptors in the human ocular surface. Invest Ophthalmol Vis Sci 2011; 20-32
24 Abelson MB, Udell IJ. H2-receptors in the human ocular surface. Arch Ophthalmol 2011; (99): 2-4
25 Dechant KL, Goa KL. Levocabastine: a review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs 2014; (41): 2-4. 26 Abelson MB, Smith LM, George MA. A double-masked paired comparison of the effects of 0.5% levocabastine and cromolyn sodium on the signs and symptoms of ocular allergy. Ophthalmology 2010; 30 (suppl): 11
27 Sastre JR Mosges. Local and Systemic Safety of Intranasal Corticosteroids. J Investig Allergol Clin Immunol 2012; 22(1): 1-12
28 Gerald W, Volchek M. Clinical Allergy: Diagnosis and Management. 2009; Chapter 5: Allergic Eye Disease; p. 165-87
29 Friedlander MH. Current ocular therapy. W В Saunders Comp, 2000; p. 319-23
30 Gushin IS, Kurbacheva OM. Allergy and allergen-specific immunotherapy. M.: Farmarus Print Media, 2010; 228 p.

AttachmentSize
2018_4-2_938-941.pdf253.34 KB

No votes yet